US court overturns bid by Ranbaxy to block launch of rival generic drugs
A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc`s heartburn pill Nexium and Roche`s antiviral Valcyte.
Nov 20, 2014, 11:06 AM IST